Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · IEX Real-Time Price · USD
0.290
-0.002 (-0.62%)
At close: Aug 12, 2022 4:00 PM
0.288
-0.001 (-0.380%)
After-hours:
Aug 12, 2022 7:58 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|
| Revenue
|
65.63 | 27.63 | 7.32 | 3.66 | 3.22 | 2.56 | 0.26 | 0.06 |
| Revenue Growth (YoY)
|
137.52% | 277.47% | 100.00% | 13.61% | 25.72% | 878.85% | 344.23% | - |
| Cost of Revenue
|
36.43 | 8.28 | 2.2 | 2.05 | 1.42 | 0.96 | 0.09 | 0 |
| Gross Profit
|
29.2 | 19.35 | 5.12 | 1.61 | 1.8 | 1.61 | 0.17 | 0.06 |
| Selling, General & Admin
|
55.81 | 31.06 | 19.24 | 17.73 | 17.61 | 8.83 | 4.29 | 2.35 |
| Research & Development
|
5.62 | 1.72 | 0.59 | 0.17 | 1.35 | 6.32 | 3.42 | 4.06 |
| Other Operating Expenses
|
26.64 | 7.7 | 2.14 | 3.41 | 2.97 | 8.16 | 0.09 | 0 |
| Operating Expenses
|
88.07 | 40.48 | 21.96 | 21.31 | 21.93 | 23.31 | 7.81 | 6.41 |
| Operating Income
|
-58.87 | -21.13 | -16.85 | -19.7 | -20.13 | -21.7 | -7.63 | -6.35 |
| Interest Expense / Income
|
0 | 0 | 0 | 0 | 2.53 | 5.49 | 0.11 | 0.05 |
| Other Expense / Income
|
-0.84 | -7.51 | 10.29 | -9.51 | -0.15 | 0.98 | 0 | 0 |
| Pretax Income
|
-58.03 | -13.62 | -27.13 | -10.19 | -22.51 | -28.18 | -7.75 | -6.39 |
| Income Tax
|
0.26 | 0 | 0 | 0 | 0 | 0 | -0.02 | -0.81 |
| Net Income
|
-58.29 | -13.62 | -27.13 | -10.19 | -22.51 | -28.18 | -7.72 | -5.58 |
| Net Income Common
|
-58.29 | -13.62 | -27.13 | -10.19 | -22.51 | -28.18 | -7.72 | -5.58 |
| Shares Outstanding (Basic)
|
17 | 5 | 1 | 0 | 0 | 0 | 0 | 0 |
| Shares Outstanding (Diluted)
|
17 | 5 | 1 | 0 | 0 | 0 | 0 | 0 |
| Shares Change
|
270.57% | 479.79% | 1071.05% | 42.83% | 10613.10% | 126.56% | 32.41% | - |
| EPS (Basic)
|
-3.48 | -3.01 | -34.80 | -153.10 | -483.00 | -64740.00 | -40280.00 | -38400.00 |
| EPS (Diluted)
|
-3.48 | -3.01 | -34.80 | -153.10 | -483.00 | -64740.00 | -40280.00 | -38400.00 |
| Free Cash Flow Per Share
|
-1.55 | -6.28 | -17.82 | -240.61 | -299.15 | -25064.91 | -34583.46 | -38066.18 |
| Gross Margin
|
44.50% | 70.00% | 69.90% | 44.00% | 56.00% | 62.60% | 66.30% | 100.00% |
| Operating Margin
|
-89.70% | -76.50% | -230.10% | -538.20% | -624.70% | -847.00% | -2915.50% | -10770.30% |
| Profit Margin
|
-88.80% | -49.30% | -370.60% | -278.30% | -698.70% | -1099.70% | -2950.30% | -9466.80% |
| Free Cash Flow Margin
|
-39.60% | -102.70% | -189.80% | -437.60% | -432.70% | -425.80% | -2534.30% | -9352.40% |
| Effective Tax Rate
|
-0.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.31% | 12.73% |
| EBITDA
|
-48.83 | -7.91 | -24.4 | -7.6 | -15.61 | -21.81 | -7.51 | -6.25 |
| EBITDA Margin
|
-74.40% | -28.60% | -333.40% | -207.60% | -484.50% | -851.30% | -2870.40% | -10604.90% |
| Depreciation & Amortization
|
9.2 | 5.71 | 2.73 | 2.59 | 4.36 | 0.87 | 0.12 | 0.1 |
| EBIT
|
-58.03 | -13.62 | -27.13 | -10.19 | -19.97 | -22.69 | -7.63 | -6.35 |
| EBIT Margin
|
-88.40% | -49.30% | -370.60% | -278.30% | -620.00% | -885.40% | -2915.50% | -10770.30% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).